Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
PARDES BIOSCIENCES INC COM
(NASDAQ:PRDS)
Intraday
Get Report
Watch
Perks
Buy
Compare Brokers
Last update: 7:00PM
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for PARDES BIOSCIENCES INC COM Stock (NASDAQ:PRDS)
PARDES BIOSCIENCES INC COM Stock (NASDAQ: PRDS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, August 28, 2023
MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share In Tender Offer For Pardes Biosciences
Happy Mohamed
-
Aug 28, 2023, 11:34AM
Thursday, August 17, 2023
MediPacific Reports Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Pardes Biosciences Shares
Benzinga Newsdesk
-
Aug 17, 2023, 5:45PM
Tuesday, July 18, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
Benzinga Insights
-
Jul 18, 2023, 11:00AM
JMP Securities Downgrades Pardes Biosciences to Market Perform
Benzinga Newsdesk
-
Jul 18, 2023, 5:22AM
Monday, July 17, 2023
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Jul 17, 2023, 1:14PM
Why Pardes Biosciences Shares Are Rising Monday
Adam Eckert
-
Jul 17, 2023, 9:25AM
Pardes Biosciences shares are trading higher after MediPacific agreed to acquire the company for $2.02-$2.19/share in cash plus contingent value rights.
Benzinga Newsdesk
-
Jul 17, 2023, 7:54AM
Pardes Biosciences Enters Into Agreement To Be Acquired By MediPacific, Inc. For Between $2.02 And $2.19 In Cash Per Share Plus Contingent Value Rights
Benzinga Newsdesk
-
Jul 17, 2023, 7:01AM
Friday, May 05, 2023
Recap: Pardes Biosciences Q1 Earnings
Benzinga Insights
-
May 5, 2023, 4:05PM
Pardes Biosciences Q1 EPS $(0.30) Beats $(0.41) Estimate
Benzinga Newsdesk
-
May 5, 2023, 4:01PM
Tuesday, April 04, 2023
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
Benzinga Insights
-
Apr 4, 2023, 11:00AM
SVB Leerink Downgrades Pardes Biosciences to Market Perform, Lowers Price Target to $2
Benzinga Newsdesk
-
Apr 4, 2023, 9:11AM
Monday, April 03, 2023
Pardes Biosciences Looks For Alternatives After Failed COVID-19 Study
Vandana Singh
-
Apr 3, 2023, 12:39PM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Apr 3, 2023, 9:06AM
Pardes Biosciences Shares Resume Trade Following News Pending Halt
Happy Mohamed
-
Apr 3, 2023, 8:33AM
Pardes Biosciences Shares To Resume Trade At 8:30 a.m.
Benzinga Newsdesk
-
Apr 3, 2023, 8:05AM
Pardes Biosciences Says Pomotrelvir Did Not Meet Primary Endpoint
Benzinga Newsdesk
-
Apr 3, 2023, 8:01AM
Pardes Biosciences Share sHalted, News Pending
Benzinga Newsdesk
-
Apr 3, 2023, 7:56AM
Wednesday, March 15, 2023
Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Mar 15, 2023, 1:20PM
Pardes Biosciences shares are trading higher after the company reported better-than-expected Q4 EPS results.
Michael Horton
-
Mar 15, 2023, 10:37AM
JMP Securities Maintains Market Outperform on Pardes Biosciences, Lowers Price Target to $5
Benzinga Newsdesk
-
Mar 15, 2023, 8:13AM
Tuesday, March 14, 2023
Pardes Biosciences Q4 EPS $(0.41) Beats $(0.50) Estimate
Benzinga Newsdesk
-
Mar 14, 2023, 4:13PM
Tuesday, January 31, 2023
Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Jan 31, 2023, 1:13PM
Friday, January 27, 2023
SVB Leerink Maintains Outperform on Pardes Biosciences, Lowers Price Target to $9
Benzinga Newsdesk
-
Jan 27, 2023, 6:48AM
Tuesday, December 13, 2022
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Dec 13, 2022, 12:14PM
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
Benzinga Insights
-
Dec 13, 2022, 10:01AM
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
Lisa Levin
-
Dec 13, 2022, 7:54AM
JMP Securities Initiates Coverage On Pardes Biosciences with Market Outperform Rating, Announces Price Target of $9
Benzinga Newsdesk
-
Dec 13, 2022, 6:38AM
Tuesday, December 06, 2022
Vapotherm, Redwire And These 2 Penny Stocks Insiders Are Aggressively Buying
Lisa Levin
-
Dec 6, 2022, 6:28AM
Monday, November 28, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Nov 28, 2022, 2:31PM
Tuesday, November 08, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Nov 8, 2022, 12:52PM
Monday, November 07, 2022
Pardes Biosciences Q3 EPS $(0.40) Up From $(3.76) YoY
Benzinga Newsdesk
-
Nov 7, 2022, 4:36PM
Tuesday, November 01, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Nov 1, 2022, 11:48AM
Thursday, October 27, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Oct 27, 2022, 12:43PM
Wednesday, October 05, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 5, 2022, 12:43PM
Monday, October 03, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Oct 3, 2022, 1:37PM
Tuesday, September 20, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 20, 2022, 12:04PM
Friday, September 16, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 16, 2022, 2:08PM
Tuesday, September 13, 2022
Pardes Biosciences Announces Commencement Of Phase 2 Trial Evaluating PBI-0451 For The Treatment Of SARS-CoV-2 Infections
Benzinga Newsdesk
-
Sep 13, 2022, 8:04AM
Monday, September 12, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Sep 12, 2022, 1:58PM
Monday, August 29, 2022
Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday
Lisa Levin
-
Aug 29, 2022, 2:55AM
Friday, August 26, 2022
Why Farfetch Is Trading Higher By 32%, Here Are 46 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Aug 26, 2022, 12:52PM
Monday, August 15, 2022
Pardes Biosciences Q2 EPS $(0.48) Down From $(0.38) YoY
Benzinga Newsdesk
-
Aug 15, 2022, 8:21AM
Monday, July 18, 2022
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Jul 18, 2022, 8:10AM
Wednesday, June 29, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Jun 29, 2022, 12:39PM
Monday, June 27, 2022
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Lisa Levin
-
Jun 27, 2022, 4:26AM
Friday, June 24, 2022
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Jun 24, 2022, 12:07PM
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Jun 24, 2022, 12:05PM
Tuesday, June 14, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Jun 14, 2022, 12:11PM
Monday, June 13, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Jun 13, 2022, 12:18PM
Show more